SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

Santa Barbara-based Lucidean, a deep-tech startup working at the cutting edge of optical interconnect technologies, has ...

The newly released 1.0 specifications are for the physical media dependent layer and transmission convergence layer ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

These inducement grants were approved by Compass Therapeutics Compensation Committee of the Board of Directors as a material inducement to employment. They were granted outside of the Company’s 2020 ...

Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

Respecting the Arera resolution to protect low-income families on the subsidized consumption band, Cittadinanzattiva Campania ...

"Nia Therapeutics publishes first in vivo validation of SNS" was originally created and published by Medical Device Network, ...

As these systems evolve, I believe therapeutic ultrasound is poised to become medicine's next general-purpose platform.

A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...